Journal article · 2021 · Open access
Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors
Chemical and Pharmaceutical Bulletin, 69(7), 620–629 · Published 30 June 2021 · DOI 10.1248/cpb.c20-01018
In brief
“Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors” is a 2021 journal article by Mingqi Huang and 9 co-authors, published in Chemical and Pharmaceutical Bulletin. OpenAlex counts 15 citations as of 19 November 2026. It is open access: the full text is free to read at Chemical and Pharmaceutical Bulletin.
- Citations
- 15
- Most cited in
- 2025 (5)
- Field-weighted impact
- 0.57
- References
- 32
- Authors
- 10
Abstract
Poly(ADP-ribose)polymerase (PARP) is a significant therapeutic target for the treatment of numerous human diseases. Olaparib has been approved as a PARP inhibitor. In this paper, a series of new compounds were designed and synthesized with Olaparib as the lead compound. In order to evaluate the inhibitory activities against PARP1 of the synthesized compounds, in vitro PARP1 inhibition assay and intracellular PARylation assay were conducted. The results showed that the inhibitory activities of the derivatives were related to the type of substituent and the length of alkyl chain connecting the aromatic ring. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)-based assay also proved that these compounds demonstrating strong inhibition to PARP1 also have high anti-proliferative activities against BRCA2-deficient cell line (Capan-1). Analysis of the entire results suggest that compound 23 with desirable inhibitory efficiency may hold promise for further in vivo exploration of PARP inhibition.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Huang, M., Ren, J., Wang, Y., Chen, X., Yang, J., Tang, T., Yang, Z., Li, X., Ji, M., & Cai, J. (2021). Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors. Chemical and Pharmaceutical Bulletin, 69(7), 620–629. https://doi.org/10.1248/cpb.c20-01018
MLA 9
Huang, Mingqi, et al. “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors.” Chemical and Pharmaceutical Bulletin, vol. 69, no. 7, 2021, pp. 620–629. https://doi.org/10.1248/cpb.c20-01018.
Chicago
Huang, Mingqi, Jinghui Ren, Yuhong Wang, Xixi Chen, Jia Yang, Tu Tang, Zhenyong Yang, Xiaojing Li, Min Ji, and Jin Cai. 2021. “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors.” Chemical and Pharmaceutical Bulletin 69 (7): 620–629. https://doi.org/10.1248/cpb.c20-01018.
Harvard
Huang, M. et al. (2021) ‘Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors’, Chemical and Pharmaceutical Bulletin, 69(7), pp. 620–629. doi:10.1248/cpb.c20-01018.
IEEE
M. Huang et al., “Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors,” Chemical and Pharmaceutical Bulletin, vol. 69, no. 7, pp. 620–629, 2021, doi: 10.1248/cpb.c20-01018.
BibTeX
@article{huang2021design,
title = {{Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors}},
author = {Huang, Mingqi and Ren, Jinghui and Wang, Yuhong and Chen, Xixi and Yang, Jia and Tang, Tu and Yang, Zhenyong and Li, Xiaojing and Ji, Min and Cai, Jin},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2021},
volume = {69},
number = {7},
pages = {620--629},
doi = {10.1248/cpb.c20-01018},
url = {https://doi.org/10.1248/cpb.c20-01018}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 2 | |
| 2022 | 1 | |
| 2023 | 2 | |
| 2024 | 1 | |
| 2025 | 5 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.57: it has been cited 0.57 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP inhibitors
- phthalazinone derivatives
- PARP1 inhibition
- olaparib
- Capan-1 cells
- antiproliferative activity
- structure-activity relationship
- alkyl chain length
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Huang, M., Ren, J., Wang, Y., Chen, X., Yang, J., Tang, T., Yang, Z., Li, X., Ji, M., & Cai, J. (2021). Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors. Chemical and Pharmaceutical Bulletin, 69(7), 620–629. https://doi.org/10.1248/cpb.c20-01018
How many times has this paper been cited?
15 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Chemical and Pharmaceutical Bulletin: sign in and open the PDF from this page.
Who wrote this paper?
Mingqi Huang, Jinghui Ren, Yuhong Wang, Xixi Chen, Jia Yang, Tu Tang, Zhenyong Yang, Xiaojing Li, Min Ji, Jin Cai.
What is the DOI of this paper?
10.1248/cpb.c20-01018, permanently at https://doi.org/10.1248/cpb.c20-01018. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.